
NeurologyLive® Friday 5 — July 18, 2025
Key Takeaways
- Simulation is being used to evaluate nonclinical competencies like communication and professionalism in neurology trainees, as previewed for the 2025 AUPN Annual Meeting.
- Veterans' health data reveals that both men and women with migraines face increased ischemic stroke risks, highlighting sex differences in migraine and stroke risk.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 18, 2025.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: AUPN 2025 Preview: Simulation as a Tool to Develop Nonclinical Competencies in Trainees
Nuri Jacoby, MD, a neurologist at Maimonides Medical Center and SUNY Downstate, previewed his talk at the 2025 AUPN Annual Meeting on using simulation to evaluate nonclinical competencies like communication and professionalism. [WATCH TIME: 3 minutes]
2: Using Veterans Health Data to Gain Insights on Sex Differences in Migraine and Stroke Risk: Elizabeth Seng, PhD
The professor of neurology at Albert Einstein College of Medicine talked about new findings presented at AHS, which suggested that both men and women with migraine can face significantly increased risks of ischemic stroke. [WATCH TIME: 5 minutes]
3: Centering Empathy in Parkinson Care by Listening Beyond the Diagnosis: María L. De León, MD
The movement disorder specialist and patient living with Parkinson disease highlighted the need for a more human-centered approach in managing chronic and progressive movement disorders. [WATCH TIME: 6 minutes]
4: NeuroVoices: Joseph S. Takahashi, PhD, on the Circadian Clock’s Impact on Metabolism, Aging and Lifespan
The professor and chair of neuroscience at UT Southwestern Medical Center offered an overview on his keynote lecture presented at AHS 2025 on the circadian clock in relation to headache.
5: Expanding Parkinson Treatment Options With Newly Approved Focused Ultrasound: Michael Kaplitt, MD, PhD
The professor of neurological surgery at Weill Cornell Medicine shared his reaction to the recent approval of the Exablate Neuro platform that uses MRI-guided focused ultrasound to treat Parkinson disease. [WATCH TIME: 5 minutes]
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.